Radioablation +/− hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)

BACKGROUND: 1. Compare SBRT +/− ADT for oligorecurrent-castration-sensitive PCa (OCS-PCa) in terms of efficacy, toxicity and Quality of Life (QoL). 2. Develop biology/imaging based prognostic tool that allows identifying OCS-PCa subclasses. METHODS: 1. Randomized clinical study (3 years for accrual...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Cancer
Egile Nagusiak: Marvaso, Giulia, Ciardo, Delia, Corrao, Giulia, Gandini, Sara, Fodor, Cristiana, Zerini, Dario, Rojas, Damaris Patricia, Augugliaro, Matteo, Bonizzi, Giuseppina, Pece, Salvatore, Cattani, Federica, Mazzocco, Ketti, Mistretta, Francesco Alessandro, Musi, Gennaro, Alessi, Sarah, Petralia, Giuseppe, Pravettoni, Gabriella, De Cobelli, Ottavio, Di Fiore, Pier Paolo, Viale, Giuseppe, Orecchia, Roberto, Jereczek-Fossa, Barbara Alicja
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Study Protocol
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6734417/
https://ncbi.nlm.nih.gov/pubmed/31500605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6117-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak